幽门螺旋桿菌诊断市场规模、份额和成长分析（按检测类型、方法、最终用户和地区）- 产业预测 2025-2032

2023 年全球幽门螺旋桿菌诊断市场规模为 6.312 亿美元，预计将从 2024 年的 6.7475 亿美元成长到 2032 年的 11.5071 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.9%。

随着早期检测对于加强疾病管理和降低医疗成本的重要性日益增加，幽门螺旋桿菌诊断市场正在获得发展动力。诊断测试，包括血液检查、呼吸检测和粪便抗原测试，可以准确识别幽门螺旋桿菌病菌感染并促进及时干预，从而改善患者的治疗效果。早期治疗可以缓解症状，加速溃疡癒合，并避免胃癌等严重併发症。非侵入性、经济高效的检测方式的出现，使得更多的患者能够接受这种检测。此外，治疗方法包括各种有效的抗生素和抑酸药，不仅可以缓解症状，还可以降低消化性溃疡的风险，最终改善患者的生活品质。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析

幽门螺旋桿菌诊断药物市场规模（依检测类型）

• 市场概况
• 侵入性
• 组织学
• 快速尿素酶检测
• 惠普文化
• 非侵入性
• 血清学检测
• 尿素呼吸检测
• 粪便抗原检测

幽门螺旋桿菌诊断药物市场规模（依方法）

• 市场概况
• 免疫检测
• 分子诊断
• 照护现场(POC)
• 其他的

幽门螺旋桿菌诊断药物市场规模（按最终用户划分）

• 市场概况
• 医院
• 诊所
• 诊断实验室
• 其他的

幽门螺旋桿菌诊断药物市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Thermo Fisher Scientific（USA）
• Bio-Rad Laboratories（USA）
• Meridian Bioscience（USA）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Quest Diagnostics Incorporated（USA）
• Abbott Laboratories（USA）
• BioMerieux SA（France）
• Cardinal Health, Inc.（USA）
• Epitope Diagnostics, Inc.（USA）
• Biohit Oyj（Finland）
• Avanos Medical, Inc.（USA）
• Quidel Corporation（USA）
• DiaSorin SpA（Italy）
• Agilent Technologies, Inc.（USA）
• Laboratory Corporation of America Holdings（LabCorp）（USA）
• Siemens Healthineers AG（Germany）

结论和建议

Global Helicobacter pylori H. pylori Diagnostics Market size was valued at USD 631.2 million in 2023 and is poised to grow from USD 674.75 million in 2024 to USD 1150.71 million by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The H. pylori diagnostics market is gaining traction, driven by the rising importance of early detection for enhanced disease management and reduced healthcare costs. Diagnostic tests such as blood, breath, and stool antigen tests enable accurate identification of H. pylori infections, facilitating timely intervention that leads to improved patient outcomes. Early treatment can alleviate symptoms, expedite ulcer healing, and avert severe complications like stomach cancer. The availability of non-invasive and cost-effective testing options increases accessibility for a broader patient population. Moreover, the treatment landscape includes a variety of effective antibiotics and acid-reducing medications that not only alleviate symptoms but also mitigate the risk of peptic ulcers, ultimately enhancing patients' quality of life.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Helicobacter Pylori H. Pylori Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Helicobacter Pylori H. Pylori Diagnostics Market Segments Analysis

Global Helicobacter pylori H. pylori Diagnostics Market is segmented by Test Type, Method, End User and region. Based on Test Type, the market is segmented into Invasive, Histology, Rapid Urease Test, HP Culture, Non-Invasive, Serologic Test, Urea Breath Test and Stool Antigen Test. Based on Method, the market is segmented into Immunoassays, Molecular diagnostics, Point of Care (POC) and Others. Based on End User, the market is segmented into Hospitals, Clinics, Diagnostic Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Helicobacter Pylori H. Pylori Diagnostics Market

The global market for H. pylori diagnostics is primarily driven by the high prevalence of H. pylori infections worldwide, affecting nearly half of the global population. This widespread occurrence of one of the most prevalent bacterial infections has led to an increased demand for reliable diagnostic tests and effective treatment solutions. Healthcare professionals and patients alike are recognizing the necessity of accurate diagnosis to mitigate health complications associated with the infection. Consequently, the growing awareness and focus on managing H. pylori infections are propelling the market forward, emphasizing the need for innovative diagnostic tools and therapies to address this public health challenge.

Restraints in the Global Helicobacter Pylori H. Pylori Diagnostics Market

The expansion of the global Helicobacter pylori diagnostics market may face challenges due to the inadequate availability of healthcare resources and diagnostic tools, particularly in developing nations. Diagnosing and treating H. pylori infections typically requires specialized equipment and medical skills that may not be readily accessible in some areas. This lack of resources can significantly hinder market growth, as patients in these regions may struggle to obtain the necessary medical care. Consequently, the overall progress of H. pylori infection management could be stunted, limiting the market's potential to thrive and impacting patient outcomes in affected populations.

Market Trends of the Global Helicobacter Pylori H. Pylori Diagnostics Market

The Global Helicobacter Pylori (H. pylori) diagnostics market is experiencing a significant upward trend, primarily driven by a growing preference for non-invasive diagnostic methods, including serology tests and urea breath tests. This shift is fueled by increasing awareness of H. pylori's role in gastrointestinal diseases and the rising incidence of related conditions such as peptic ulcers and gastric cancer. The convenience and comfort of these minimally invasive tests are propelling their adoption among healthcare providers and patients alike. Additionally, advancements in technology and the integration of rapid testing options are further enhancing market growth, positioning non-invasive diagnostics as the preferred choice in H. pylori detection.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Helicobacter pylori H. pylori Diagnostics Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Invasive
• Histology
• Rapid Urease Test
• HP Culture
• Non-Invasive
• Serologic Test
• Urea Breath Test
• Stool Antigen Test

Global Helicobacter pylori H. pylori Diagnostics Market Size by Method & CAGR (2025-2032)

• Market Overview
• Immunoassays
• Molecular diagnostics
• Point of Care (POC)
• Others

Global Helicobacter pylori H. pylori Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinics
• Diagnostic Labs
• Others

Global Helicobacter pylori H. pylori Diagnostics Market Size & CAGR (2025-2032)

• North America (Test Type, Method, End User)
  • US
  • Canada
• Europe (Test Type, Method, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Method, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Method, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Method, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epitope Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biohit Oyj (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avanos Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings (LabCorp) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations